🏥 ISO 13485
ISO 13485:2016 Medical Stamping Suppliers
Stamping a surgical staple or a stent frame is a precision-forming problem layered on top of a regulatory one, and ISO 13485:2016 is what governs the second layer. The biggest surprise for shops crossing over from commercial work is process validation: when a stamped output can't be fully verified by inspection, the process itself has to be validated through IQ/OQ/PQ. Below, what the standard demands inside a medical press shop, how it ties to FDA 21 CFR 820 and EU MDR, and why the supplier base is so narrow.
ISO 13485ISO 9001FDA Registered
ISO 13485:2016 is a stand-alone medical-device QMS standard. It shares architecture with ISO 9001 but diverges sharply in risk emphasis and record-keeping. For a stamping shop the defining requirements are documented process validation, tight design and process change control, full traceability through a Device History Record, and contamination control appropriate to the device's classification.
Process validation is the requirement that catches commercial stampers off guard. Clause 7.5.6 distinguishes between verification (you confirm the result by measuring the part) and validation (you cannot, so you must prove the process reliably produces conforming output). Many stamped dimensional features can be verified, but cleaning, deburring, passivation, laser marking, and any joining or coating step frequently fall into the validation bucket, requiring IQ/OQ/PQ, Installation, Operational, and Performance Qualification, each with documented protocols, sampling plans, acceptance criteria, and revalidation triggers.
Material control is stricter and narrower than commercial work. Medical stamping concentrates on biocompatible, corrosion-resistant alloys: 316L and 17-4PH stainless, titanium grades 2 and 5, nitinol for self-expanding components, MP35N, and platinum-iridium for radiopaque markers. Mill certs, traceability to the heat lot, and control of materials of concern are mandatory, and the shop must maintain the full DHR linking each lot of stamped parts to its material, process records, and inspection data.
Where the Standard Meets FDA 21 CFR 820 and EU MDR
ISO 13485 certification and regulatory registration are distinct, and conflating them is a frequent sourcing error. ISO 13485 is a voluntary international QMS standard verified by a certification body. FDA establishment registration is a separate regulatory obligation under the US Quality System Regulation, 21 CFR 820, which the FDA is harmonizing toward ISO 13485 under its Quality Management System Regulation transition. A stamping supplier can hold one without the other, so confirm both independently when your device requires it.
For a contract stamping supplier, whether FDA registration applies depends on its role and what the device maker requires. Many medical OEMs require their stamping suppliers to be FDA-registered contract manufacturers operating under a signed quality agreement that covers complaint handling, CAPA, change notification, and record retention; others retain those obligations themselves and require only ISO 13485 from the component supplier. If your device is sold in Europe, EU MDR adds its own expectations on technical documentation and supplier control that flow down to the stamping shop. The clean approach is to pin down, in the quality agreement, who owns validation, who pays for revalidation after a change, and what change-notification obligations the supplier carries, because an unplanned revalidation can stall a device's supply for months.
Why Medical Stamping Is a Narrow Specialty and What It Covers
Medical-device OEMs are essentially the only buyers of ISO 13485 stamping, but the part range is wide: surgical instrument components, bone plates and orthopedic hardware blanks, stamped implant components, stent and stent-frame precursors, battery and feedthrough components for implantable electronics, surgical staples, and stamped contacts and shields inside diagnostic and monitoring equipment.
There is a meaningful split inside medical. Class I and many Class II device components can be stamped under ISO 13485 with standard validation rigor. Implantable and Class III components, especially anything in nitinol, titanium, or MP35N destined for the body, demand the tightest cleanliness, full validation, and additional supplier controls flowed down by the device maker. Precision micro-stamping of contacts, springs, and shields for active implantable devices is its own niche, with sub-0.001 inch tolerances and punch wear measured in microns.
Adjacent regulated work occasionally borrows ISO 13485 discipline outside finished devices, for example high-cleanliness stamped components for semiconductor or analytical instruments where the medical-grade documentation and contamination control are valued, though those buyers more often specify ISO 9001 plus a cleanliness spec. The honest framing is that this is a low-volume, high-documentation specialty, far less common than ISO 9001 or IATF stamping, and you should expect a shorter supplier list and higher per-part economics.
Verifying the Certificate and Aligning the Quality Agreement
Check the certificate for registrar, certificate number, scope, and dates, then validate it on the registrar's online client directory. The scope must cover manufacture of medical-device components or stampings; a generic stamping scope without medical language is a warning sign because the audit depth differs substantially. Confirm the registrar is accredited by an IAF MLA signatory such as ANAB.
Because certification does not equal FDA registration, separately confirm whether the supplier is FDA-registered as a contract manufacturer and whether it will support your quality agreement, complaint handling, and CAPA flowdown. Ask specifically about notification of change: ISO 13485 obligates the supplier to control changes, but you want contractual notification before any process or material change touches your part. For implantable or high-risk components, request evidence of process validation (IQ/OQ/PQ summaries), cleanliness and bioburden control, and material-traceability practices. On ManufacturingBase you can filter for ISO 13485 stamping suppliers and review certification detail, then validate the certificate and align quality-agreement expectations directly with the shop before tooling.
Frequently Asked Questions
ISO 13485 stamping is a real but narrow specialty, far less common than ISO 9001 or automotive IATF stamping, because the buyer base is essentially limited to medical-device OEMs and their contract manufacturers. You need an ISO 13485 stamping supplier when a stamped part becomes a component of a medical device, instrument, or implant and the device maker flows down a medical QMS requirement, which they almost always do for anything beyond the lowest-risk parts. The honest nuance is that not every metal part touching a medical product requires an ISO 13485 stamper. A non-contact bracket inside a cart or an enclosure shield in diagnostic equipment may be acceptable from an ISO 9001 shop under the device maker's own controls. But anything patient-contacting, implantable, or in the sterile fluid or instrument path will require ISO 13485, with the validation and traceability that come with it. If your part is a stent frame, a bone-plate blank, a surgical instrument component, or an implant feedthrough, ISO 13485 is mandatory and you should also confirm FDA registration and a quality agreement. When in doubt, ask your regulatory team where the part sits in the device's risk classification, because that determines the requirement, not the geometry of the stamping.
Medical stamping concentrates on a short list of biocompatible, corrosion-resistant alloys: 316L and 17-4PH stainless, commercially pure titanium (grade 2) and Ti-6Al-4V (grade 5), nitinol (a nickel-titanium shape-memory alloy used in stents and self-expanding devices), MP35N (a cobalt-nickel-chromium-molybdenum alloy with high strength and fatigue resistance), and platinum-iridium for radiopaque markers in implantable electronics. These are expensive for several reasons. Nitinol, MP35N, and platinum-iridium are priced per gram rather than per pound, so material cost can dwarf the press time on a small part. They require full mill traceability to the heat lot, control of materials of concern, and often raw-material testing, which lengthens titanium and nickel-cobalt procurement to 8 to 16 weeks. Nitinol in particular needs tight control of its transition temperature and is sensitive to forming and heat treatment, adding process complexity. Material can easily be the majority of a small implant-grade part's cost, so when you quote, ask whether pricing is firm or index-linked, what scrap and yield assumptions apply, and how the shop manages traceability, because documentation and yield on these alloys drive the price as much as the alloy itself.
Yes, when a process output cannot be fully verified by inspecting the finished part. ISO 13485:2016 clause 7.5.6 distinguishes verification (you confirm the result by measuring the part) from validation (you cannot, so you must prove the process reliably produces conforming output). Pure dimensional stamping features can often be verified, but cleaning, passivation, deburring, laser marking, coating, and any joining step commonly require validation through IQ/OQ/PQ: Installation, Operational, and Performance Qualification, each with documented protocols, sampling plans, acceptance criteria, and revalidation triggers. A full IQ/OQ/PQ on a stamping-related process typically costs $10,000 to $50,000 and adds 8 to 16 weeks to the program, and it must be repeated whenever the validated process changes, which is why change control is governed so tightly. This is a major reason medical stamping runs slower and more expensive than commercial stamping and why volumes are usually low to mid. When you scope a medical stamping project, agree up front in the quality agreement on who owns validation, who pays for revalidation after a change, and what change-notification obligations the supplier carries, because an unplanned revalidation can stall your device's supply for months.
No. ISO 13485:2016 certification and FDA establishment registration are separate, and a supplier can hold one without the other. ISO 13485 is a voluntary international QMS standard verified by a certification body, while FDA registration is a regulatory obligation under the US Quality System Regulation (21 CFR 820, now harmonizing toward ISO 13485 under the FDA's Quality Management System Regulation transition). For a contract stamping supplier, whether FDA registration applies depends on its role and what the device maker requires. Many medical-device OEMs require their stamping suppliers to be FDA-registered contract manufacturers operating under a signed quality agreement covering complaint handling, CAPA, change notification, and record retention; others retain those obligations themselves and require only ISO 13485 from the component supplier. The practical step is to confirm both separately: validate the ISO 13485 certificate on the registrar's directory, and confirm the supplier's FDA registration status and willingness to sign your quality agreement before production. On ManufacturingBase you can filter ISO 13485 stamping suppliers and review certification and registration detail, but still align the regulatory and quality-agreement expectations directly with the shop, because these obligations are part-specific and contractual, not implied by the certificate alone.
Last updated: July 2026
Find ISO 13485-Certified Stamping Suppliers
Search verified stamping shops that hold ISO 13485.
No logins. No email gates. Just results.